Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00416221 · ClinicalTrials.gov registry record · NA
PACEPro - Mood Management Pilot
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00416221 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 40 participants.
The verdict
NCT00416221, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Researchers at the University of California at San Diego (UCSD) are conducting a 12-week study to test the PACEPRO program. This program is designed to reduce depression by providing: Lexapro, an antidepressant medicine…Learn More Physical activity information and pedometer Mood management skills and a Mood Mastery Guide Personalized support from a Family Nurse Practitioner
Interventions
- BEHAVIORAL Physical Activity
- DRUG Lexapro, an antidepressant medicine
- BEHAVIORAL Mood Management Skills
- BEHAVIORAL Personalized support from a Family Nurse Practitioner
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2006-04 |
| Est. Completion | 2007-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00416221
The ClinicalTrials.gov registry entry for NCT00416221 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Physical Activity is the first listed.
NCT00416221 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00416221 about?
NCT00416221 is a clinical study titled "PACEPro - Mood Management Pilot". Researchers at the University of California at San Diego (UCSD) are conducting a 12-week study to test the PACEPRO program. This program is designed to reduce depression by providing: Lexapro, an antidepressant medicine…Learn More Physical activity information and pedometer Mood management skills a...
What is the current status of trial NCT00416221?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2006-04. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00416221?
The interventions under investigation include: Physical Activity (BEHAVIORAL), Lexapro, an antidepressant medicine (DRUG), Mood Management Skills (BEHAVIORAL), Personalized support from a Family Nurse Practitioner (BEHAVIORAL).
Who is sponsoring clinical trial NCT00416221?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.